key: cord-0726604-e563p9av
authors: Hickman, Cristina; Rogers, Shaun; Huang, Guoning; MacArthur, Steven; Meseguer, Marcos; Nogueira, Daniela; Portela, Rafael; Rienzi, Laura; Sharp, Timothy; Ye, Hong
title: Managing the IVF laboratory during a pandemic: International perspectives from laboratory managers
date: 2020-05-21
journal: Reprod Biomed Online
DOI: 10.1016/j.rbmo.2020.05.006
sha: c9dbf3f3d24a034b628bb2cd374b21d09150b064
doc_id: 726604
cord_uid: e563p9av

ABSTRACT Fertility societies worldwide responded to the Covid-19 pandemic by recommending that fertility clinics close, or sharply reduce the clinical operation, leading to a shift in the management of IVF laboratories in three phases: (1)Shutdown preparation; (2)Maintenance during shutdown; (3)Restart. Each of these phases carries distinct risks that need identification and mitigation, forcing laboratory managers to rethink and adapt their procedures in response to the pandemic. The sudden and unprecedented nature of a pandemic forced lab managers from around the world to base decisions on personal opinion and experience when evidence-based response options were unavailable. These perspectives on pandemic response were presented during a virtual international symposium on Covid-19, held on 3 April, 2020, and organised by the London Laboratory Managers’ Group. Laboratory managers from seven different countries at different stages of the pandemic (China, Italy, Spain, France, UK, Brazil, Australia) presented their personal experiences to a select audience of experienced laboratory managers from 19 different countries. . The intention of this paper is to collect the learnings and considerations from this group of lab managers who collaborated to share personal experiences to contribute to the debate surrounding what constitutes good IVF laboratory practice in extraordinary circumstances, such as the Covid-19 pandemic.

On the 12 th of March 2020, the World Health Organisation declared the SARS-Cov2 (Covid-19) outbreak a pandemic. Several fertility societies worldwide (ESHRE, 2020a,b; ASRM, 2020a,b ; BFS & ARCS, 2020; Agence de la Biomédecine, 2020; SIERR, 2020; SIFES, 2020; CSRM, 2020, ASEBIR 2020) responded by recommending that fertility clinics cease IVF treatment, with the exception of essential medical fertility preservation, in order to protect staff and patients from unnecessary exposure to the virus (particularly given the unknown risk during pregnancy), while also allowing resources to be redeployed to frontline medical staff treating Covid-19 patients. The decision to close, or sharply reduce the clinical operation of IVF clinics, led to a shift in the management of IVF laboratories in three phases:

(1) Shutdown prepartion (2) Shutdown maintenance (3) Restart Each of these phases carries distinct risks that need identification and mitigation, forcing laboratory managers and directors to rethink and adapt their procedures in response to the pandemic.

The sudden and unprecedented nature of the pandemic forced lab managers from around the world to base decisions on local society and government advice, as well as personal opinion and experience when evidence-based responses were unavailable. These perspectives on how to respond to a pandemic were presented during a virtual international symposium on Covid-19, held on the 3rd of April, 2020, and organised by the London Laboratory Managers' Group (2020). Laboratory managers from seven different countries at different stages of the pandemic (China in phase 3, Italy, Spain and France in phase 2, UK transitioning into phase 2, Brazil and Australia in phase 1; Table 1 ) presented their personal experiences to a select audience of experienced laboratory managers from 19 different countries (Australia, Austria, Belgium, Brazil, China, Denmark, France, Germany, Greece, Italy, Japan, Malaysia, Mexico, New Zealand, Saudi Arabia, Spain, Sweden, UK, USA), with attendees sharing how they personally responded to the Covid-19 pandemic.

The intention of this paper is to collect the learnings and considerations from this geographically-diverse group of lab managers who collaborated to share personal experiences within the context of the guidelines provided by their local professional societies and governments. The proceedings reflect similarities as well as variations of opinion and practice, and can add to the debate surrounding what constitutes good IVF laboratory practice in extraordinary circumstances, such as the current Covid-19 pandemic.

When establishing processes for a planned shutdown due to Covid-19, the lab managers adopted standard protocols routinely performed for short term laboratory closures. Expanding these established routines to include elements of emergency/disaster recovery procedures (ASRM, 2016) , allowed the laboratory team to become prepared to cease activity. The main difference to a 'standard emergency' was building in the factors to mitigate the possibility of harm being caused by an infectious agent that potentially can enter the laboratory either via patients or the staff.

Leadership and communication are key to maintaining staff morale, as is establishing a cohesive approach throughout the clinic. The clinic management team, the laboratory and medical director may consider establishing a themed action plan.

The "business/clinical contingency plan":

• sets out to help manage patients, staff and others who are associated with the clinic, including suppliers and governmental bodies; • ensures compliance with guidelines provided by local governments and national or international professional societies.

In line with the clinic's business contingency plan, lab managers considered the following:

• constructing a revised process map for the IVF laboratory;

• identifying areas within the emergency action plan that can be applied; • contingencies required for maintenance of cryo-stored material: ○ liquid nitrogen delivery -maintaining communication with the suppliers of liquid nitrogen or seeking alternative suppliers -eg from a research facility, university, or the food industry; ○ training non-laboratory staff to assist with liquid nitrogen tank top-ups; ○ movement of material to long term storage facilities for safety purposes; • formulating reciprocal support agreements with nearby clinics in support of the continuation of care, so that patient care can progress should, for instance, a clinic have to close suddenly (due to insufficient staff for example).

Regarding indemnity and liability, lab managers considered the following:

• reviewing regulatory and legal requirements when planning to perform treatment in a third-party laboratory under a reciprocal support agreement.

• determining the need for additional indemnity insurance coverage in the event the manipulation and cryopreservation of gametes and embryos performed in the clinic of origin by external staff or in another clinic, should patient care be transferred elsewhere.

Initial stages of the pandemic may lead to insufficient staff being available to handle the clinical workload. Staff may themselves become ill, or be in a high risk group and, therefore, be advised to stay at home, need to care for a family member, or deployed to other services in public healthcare. To avoid potential staff shortages, several laboratory managers split their laboratory team into groups and shifts. This helped reduce the number of embryologists present in the clinic at any one time and in itself, formed a backup system. This decision also helped in ensuring that a sufficient number of team members are available, should a need arise to quarantine particular staff members.

Organising teams of senior and junior embryologists has been easy to achieve for larger IVF units, but for smaller groups, this is a challenge, especially when satisfying the requirements of local legislation. It appears that fluid and informal arrangements to provide emergency cover have been forged by and between laboratory managers in different regions, designed to help ensure that support is available when necessary. These arrangements need to be formalised to ensure that suitable staffing and orientation programs can be organised, highlighting how competency can be demonstrated in the host laboratory and the processes supervised. This can be performed during the shutdown period and therefore on short notice. In retrospect, some of the larger programs operating multiple clinics in more than one city may consider whether centralising activities will be sufficient to scale-down services.

In clinics where laboratory staff are involved with direct patient communication, laboratory staff supported patients through discussion of infection risk, current evidence, to clarify areas where information is not known, and through referral towards implication counselling to provide patients who are disappointed that treatment will need to stop for an indefinite time period.

The lab manager may consider modifying standard protocols for patient communication, their visits to the clinic, culture procedures and vitrifying all embryos in culture, at an appropriate stage. Several local fertility societies have encouraged clinics to advise couples to avoid embryo transfer in their attempt to achieve a pregnancy (ESHRE, 2020a,b; ASRM, 2020b; BFS & ARCS, 2020; Agence de la Biomédecine, 2020; SIERR, 2020; SIFES, 2020; CSRM, 2020, ASEBIR, 2020).

IVF laboratory managers considered:

• Utilising teleconferencing, email and telephone calls for all patient communication.

• Ensuring staff are available to answer patient queries.

• Ensuring counselling staff are aware of clinic closure plans and available to provide patient support, where necessary.

Procedures to temporarily decommission equipment to reduce unnecessary running costs during an extended shutdown were verified with the equipment manufacturers and/or distributors to ascertain the best practice for short or long term equipment inactivity; taking into account:

• Potential for contamination in humidified incubators.

• The age of equipment and whether keeping the item on a 'low running' mode would be beneficial at startup. • Use of HEPA filtration or air purifications systems during close down • Time required for restart of equipment.

To prepare for an extended shutdown for an undetermined period of time, IVF laboratory managers considered:

• Increasing their back-up power supply, particularly when using inline UPS. Only critical equipment remained connected to the UPS. • Daily alarm tests were set-up, verifying the callout function. • Identifying suppliers' delivery contingency plans, sourcing alternative options for essential items such as liquid nitrogen and medical gases.

During the shutdown, the IVF laboratory is responsible for maintaining the equipment and the cryostorage inventory with limited staff and resources. The laboratory managers considered preparing for a worst-case scenario, where liquid nitrogen may not be available for delivery or following a distribution failure. By identifying these risks in advance, the clinic can prepare contingencies to mitigate the identified risks.

Due to the nature of cryogens and the risks of storage of liquid over a long period of time, the IVF laboratory is suggested to focus on reducing liquid nitrogen supply interruption. The following were identified as important to minimising interruption risk and:

• Understanding how the gas supplier manages the lab's account and whether they prioritise medical accounts and can provide assurance that supplies will not be interrupted. • Sourcing a secondary supplier in case the main supplier is unable to meet the demand. It is advisable to source a secondary supplier who sources their liquid nitrogen from a different gas generator company. • Contacting state or local departments of health and local police (perhaps in certain more remote localities or those with strict traffic restrictions) to make them aware that the IVF clinic is a medical facility and will be receiving gas or emergency supplies. This may also be important if laboratory staff are travelling to and from the IVF clinic to avoid travel delays.

To minimize liquid nitrogen loss and other risks during a shutdown period, the managers discussed the following:

• Avoiding unnecessary opening of the units to reduce evaporation.

• Calculating normal evaporation rate for each dewar and monitoring for unusual loss particularly for units older than 5 years. The evaporation rate can be used to guide storage of samples if consolidation is a possibility, and to be aware of which dewars may have a higher risk of failure. • Limiting physical measurement of nitrogen levels in dewars to once per week, whilst topping up the dewar with liquid nitrogen on the other daily checks. • Stockpiling large amounts of liquid nitrogen is not advisable due to continuous evaporation and loss of product. Maintaining dewars as full as possible is advisable over stockpiling supply tanks. • Avoiding or limiting moving of dewars to reduce liquid nitrogen splashing into the collar and the resulting loss. Laboratory managers considered placing dewars in areas where movement was minimised. • Recording and maintaining a filling schedule to avoid opening the dewars for unnecessary activities. ○ This will also make it easier to identify signs of distress or sweating or any of the other aspects of dewar failure, based on when the dewar was last filled. ○ Have a positive confirmation when a dewar is filled through the check sheet

The following were considered important by the managers:

• Ensuring all laboratory staff are aware of and understand the emergency response plan. • Ensuring the alarm call schedule is up to date and that the first responder always is within 1 travel hour from the clinic. • Testing alarms and back-up power facilities. • Monitoring equipment QC parameters to ensure satisfactory performance during shutdown. • Assessing environmental conditions in the laboratory, including room temperature, humidity, and air handling unit function.

It was the opinion of the managers that on site staffing should be limited to:

• support essential treatment, such as fertility preservation for oncological patients;

• support cryostorage management, dewar maintenance and liquid nitrogen top up; • check expiry date of consumables and media, remove expired items and receive essential items that may be delivered;

• maintain laboratory equipment.

• All other staff are enabled to work from home, to take the opportunity to update the quality management system with reviewed standard operating procedures, and other tasks that can be conducted remotely.

In order to maintain staff morale, some clinics have kept virtual meetings where staff can still see each other and can discuss non-work related matters to maintain team camaraderie, and support the emotional wellbeing of the staff. It is also an opportunity to check on the mental health of the team during the pandemic. Other clinics have set up daily/weekly update meetings which can reduce anxiety among staff members.

Following a major operations interruption event, through direct communication with other departments and the management of the clinic, the laboratory managers focused on making the laboratory team aware of the clinic's re-starting plans (part of the business/clinical contingency plans). The re-starting part of the plan anticipates the volume of patients to be treated over time from which the laboratory's complimentary restarting plan is devised, and agreed by the clinical team. The laboratory re-starting plan includes a process-map to ensure the following:

• staffing is sufficient for the anticipated volume of patients;

• decontamination and validation of equipment before first use;

• adequacy of supplies of consumables ;

• completion of risk assessments specific to viral contamination;

• review of laboratory procedures in line with risk assessment mitigations;

• staff competencies are re-evaluated for revised procedures.

Pandemics have a lifespan, so that the risk to the laboratory will diminish over time past the peak, and will eventually be eliminated. Therefore, it is important that plans are reviewed and evolved regularly, in line with the pandemic cycle stage, and any changes are communicated to the rest of the clinic and laboratory teams.

In a pandemic involving a virus, the risk assessment considered the nature of transmission in order to correctly identify the laboratory procedures that need to be adapted to protect patients, staff, gametes and embryos. A respiratory virus transmitted via aerosol requires different process adaptations than viruses transmitted via other bodily fluids.

A patient may infect a member of staff via aerosols if they are in close proximity. Therefore, clinics have considered the following changes in laboratory practice to mitigate this risk:

• reducing face-to-face contact with patients where possible. In clinics where embryologists normally communicate face-to-face with patients, phone, telecommunication or patient-facing apps are being considered or have been implemented as an alternative form of communication. • avoiding patients sharing tools / instruments, for example, fingerprint identification readers, pen and clipboards, and tablets for data entry / information / entertainment. • introducing patient and staff screening for Covid-19 (including viral load, antigen testing when available or temperature checks and/or epidemiological survey). Patients screening/triage may occur before, during and after treatment. In these cases, the laboratory will need to implement processes to receive this information; • using PPE at all times; • Increase hand washing routines; • disinfecting procedure rooms, semen collection rooms, and other patient areas in between patients; • increasing air exchange in rooms utilised by patients to at least 2 air changes per hour; • increasing time between procedures to permit sufficient air renewal; • separate couples/patients in individual waiting rooms prior to procedures.

It is standard embryology practice to assume that all biological samples may potentially be infectious. As such, semen and follicular fluid are processed using universal precautions. The lab manager may consider re-enforcing these standards when restarting the lab.

All laboratory managers who participated agreed that all in vitro fertilisation procedures, including; ICSI, oocyte denudation, vitrification and embryo transfer should be modified to include multiple dish changes / cell washes with new media to effect a dilution of any potential infective agent and, therefore, limit risk of the virus presence in the culture environment.

Some clinics have chosen to continue using Laminar Air Flow Hoods for these processes, whilst others have chosen to exclusively use class II Hoods during the pandemic.

Preliminary and unpublished reports of detection of coronavirus in semen from Covid-19 patients, lead some lab managers initially to consider the following cautious adaptations to routine practice to reduce contamination risk from semen:

• extra care in semen handling; • semen cryopreservation in closed systems;

• changing consumables per patient (eg. Increasing pipet usage); • offering ICSI for all patients during the pandemic cycle;

• individual culture of zygotes after ICSI;

• avoid touching cryo straw without gloves during each phase of cryopreservation (labelling, loading, storing); • specified liquid nitrogen containers during pandemic period • use of sterile nitrogen for sample washing at warming (Parmegiani et al., 2012) .

One recent publication suggested absence of viral particles in semen or testicular biopsy specimens obtained from men recovering from Covid-19 (Pan et al. 2020), while a second paper (Li et al., 2020) reported semen samples positive for SARS-CoV-2 during acute infection, although no proof of potential infectivity was provided. Thus, the data appear to be inconclusive. As such, it is questionable whether the protective procedures associated with HIV, hepatitis B and C and Zika are applicable to Covid-19. Hence, the suggestions above were no longer considered necessary. Several lab managers agreed that the use of a closed system for cryopreservation merits consideration from a contamination risk perspective, although the reported increased success rate associated with open systems meant that this opinion was not unanimous. Similarly, the need to sterilise liquid nitrogen was not considered a necessity by all.

Screening staff for Covid19 infection or immunity would be the preferred first step by laboratory managers in mitigating against staff as a source of contamination. However, the availability of testing is currently limited. Moreover, it is not clear whether virus shedding occurs whilst a person is asymptomatic, or infectious before the test can diagnose Covid-19. As such, laboratories have chosen to treat all staff as potentially infectious and adapted their processes accordingly by engaging in social distancing with increased infection control measures.

• Using PPE at all times.

• increased awareness of staff in order to reduce touching faces and surfaces unnecessarily, sterilising the workstations, including the ocular of the microscopes before and after each use, sterilising the cryo-tanks external surfaces after each use.

Evidence is still tentative regarding the length of time the virus can survive in aerosol and on different surfaces (Doremalen et al., 2020) . A professional disinfection of the laboratory with detergent/sanitizer agents was considered before the staff returned. Laboratory managers took into account the type and concentration of sanitiser used, and the amount of time the laboratory is ventilated before clinical cases commence, to ensure that the environment is safe for gametes and embryos. Therefore, it was agreed that efforts are made to verify that disinfectants were VOC and embryo-toxin free. Some laboratory managers suggested solutions of quaternary ammonium (SIERR, 2020).

The frequency of disinfection during clinical activity has varied between clinics, but all clinics have opted to increase their decontamination frequency. It is not feasible to swab surfaces to determine efficacy of disinfection. Therefore, managers considered disinfecting workstations in between patients as well as in between embryologists. In effect any area a member of staff has touched is to be considered a high risk area.

Before the pandemic, laboratory managers considered the technical and operational requirements for assisted reproduction technology laboratory air quality as previously described in Mortimer et al (2018) . In responding to the pandemic, IVF laboratories with the air-handling technology available considered disinfecting the air of the rooms used by patients using a photocatalyst air sterilizer. This will not be possible in clinics where this technology is not available. Alternatives include ventilating the room to achieve at least two complete air changes in between patients. Limiting the number of patients that can be scheduled for egg collection, masturbation or embryo transfer to a maximum of one patient per room per hour could be sufficient.

During the shutdown, several equipment will have been decommissioned. Recommissioning the equipment requires decontamination and re-validation of the operational performance. These validations were performed and validated as per protocol for all critical equipment.

There is inconsistency among clinics as to what PPE should be used during routine IVF, as well as under current pandemic conditions. Surgical masks and gloves are worn throughout the time inside the IVF lab in some labs; while others wear masks and gloves only during procedures.Yet others wear gloves only when handling semen and follicular fluid and only wear gloves and masks when handling samples while handling samples for genetic analysis procedures.

Lab managers had a variety of views on what is considered appropriate protective equipment when performing procedures. With the onset of the pandemic, all laboratory managers considered increasing PPE usage requirements, in line with varied recommendations in different countries:

• All lab managers agreed that long sleeved-scrubs or surgical gowns or lab coats (either disposable single use or single use between high temperature wash), dedicated footwear and hair covers are worn throughout the time in the lab • The lab managers agreed that surgical masks and gloves are worn during procedures; • Most lab managers have considered extending the use of the masks and gloves throughout the time in the IVF laboratory, maintaining the mask untouched during use, and changing masks at least every 4 hours; • Most lab managers agreed that N95 masks were not necessary in the lab; • Most lab managers agreed that protective face shields were not practical for microscopy and micromanipulation work; • Most lab managers agreed that goggles or eye protection could be considered throughout the time in the lab, when practical during microscopy and micromanipulation.

If gloves and masks are worn, these were changed regularly; masks were not touched whilst being worn, and the wearing of gloves did not replace the regular and thorough washing of hands for at least 20 seconds each time. This will impact the productivity of the embryologist and the number of cycles per day was adjusted accordingly.

HEPA (High Efficiency Particle Air) filters can filter 97% of 0.3m particles from the air. However, respiratory droplets can vary in size from 0.01-10um. Therefore, the HEPA filters cannot block the Coronavirus completely, although increased air changes with reduced air recycling settings is expected to help reduce viral contaminants in the air.

Depending on the capabilities of the air handler, changing these settings may increase air temperature variation, which may in turn impact the incubator and heated stage performance. As such, lab managers considered changing the air handling settings before the validation of other equipment.

Social distancing in the laboratory means that the number of staff in the laboratory at any one time will need to be reduced. Technologies involving automation can help optimise the embryologists' time. Examples include: • Electronic witnessing system or telematic witnessing; • Time-lapse incubation (allowing remote embryo assessment); • Uninterrupted single-step culture;

• Automated filling of the liquid nitrogen vessels;

• Automated storage of samples in the storage tank; • Automated equipment monitoring and alarm systems (allowing remote QC evaluations).

The standards of practice laid out by ESHRE Good laboratory practice (2015) continue to be the backbone in standards of how we manage our IVF laboratories. In this paper, we have outlined additional measures employed by laboratory managers around the world in response to the Covid-19 pandemic, without pandemic-specific guidelines being available. A lot is still unknown about this virus and its impact on our work as we treat patients. To date, laboratory managers have had to make decisions and take action with a lack of scientific evidence, and, therefore, this paper was not meant to be a consensus of good practice, but rather presentation of different approaches taken by laboratory managers from different countries. Covid-19 is not the first or the last emergency crisis that IVF laboratory managers will have to face. This particular experience will hopefully provide laboratory managers a unique perspective on how to plan for and deal with future major events that lead to interruption of IVF services. The practices outlined in this paper will hopefully help formulate good practice for any IVF laboratory responding to a pandemic: whether this pandemic, or the next.

Gianzo, M., Urizar-Arenaza, I., Muñoa-Hoyos, I., Larreategui, Z., Garrido, N., Casis, L., Irazusta, J., Subirán, N., 2018. Human sperm testicular angiotensin-converting enzyme helps determine human embryo quality. Asian J Androl. (5) Consider decommisssioning work stations) ❏ Calculate and implement maximum lab occupancy (minimum 4m2 per staff member) ❏ Restrict laboratory staff from entering general patient areas. ❏ Increase glove wearing and change over when handling equipment. ❏ Consider eye protection when it does not impair equipment use (i.e. difficulty in using eye protection during microscopy). Consider visualising microscope images through a screen rather than through microscope binoculars, where appropriate ❏ Use embryo safe hand washes before and after applying gloves. ❏ Mask and goggle use mandatory when handling liquid nitrogen.

Risk of staff becoming contaminated by laboratory environment Insufficient evidence at the moment but prudent to consider: ❏ Additional PPE as described above ❏ Increase number of air change overs ❏ Consider a deep clean before restarting ❏ Consider increasing cleaning requirements when operational in terms of procedure and frequency ❏ Utilise UV sterilisation during periods of inactivity / no gamete or embryo handling ❏ Retain the minimal worker / rotational split teams procedure ❏ Consider disposable scrubs or consider how the scrubs are laundered Critical equipment non-conforming ❏ Assess monitoring data for critical equipment during shutdown. Quarantine non-confirming equipment ❏ Re-validate equipment that was temporarily decommissioned during shutdown before re-use

American Society of Reproductive Medicine. Patient management and clinical recommendations during coronavirus (Covid-19) pandemic. Second update published 13th

American Society of Reproductive Medicine Issues New guidance on fertility care during Covid-19 Pandemic: Calls for suspension of most treatments

British Fertility Society / Association of Reproductive & Clinical Scientists, Guidance for the care of fertility patients during the Coronavirus COVID 19 Pandemic

-7) in human follicular fluid correlates with oocyte maturation

Covid-19: the perspective of Italian embryologists managing the IVF laboratory in pandemic emergency

An updated statement from ESHRE 2

th April date last accessed) Fertility Society of Australia Covid Response Committee Statement

Ubaldi. F. M., 2020. Covid-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine Reprod BioMed Online

Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1